Aventamed DAC

- Country
- 🇮🇪Ireland
- Ownership
- Subsidiary
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.aventamed.com
Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Post-Market Clinical Follow-Up Study of the Solo+ Tympanostomy Tube Device
- Conditions
- Otitis MediaMiddle Ear Infections
- First Posted Date
- 2025-06-19
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- AventaMed DAC
- Target Recruit Count
- 160
- Registration Number
- NCT07029997
In-Office Clinical Study of the Solo+ TTD
- Conditions
- Otitis MediaEar Infection
- First Posted Date
- 2023-02-23
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- AventaMed DAC
- Target Recruit Count
- 66
- Registration Number
- NCT05741333
- Locations
- 🇺🇸
Southern Head & Neck Surgery, Alexander City, Alabama, United States
🇺🇸North Alabama ENT, Huntsville, Alabama, United States
🇺🇸East Alabama ENT, Opelika, Alabama, United States
Clinical Study of the Solo+ Tympanostomy Tube Device
- Conditions
- Otitis MediaEar Infection
- First Posted Date
- 2019-11-01
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- AventaMed DAC
- Target Recruit Count
- 27
- Registration Number
- NCT04148417
- Locations
- 🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
Clinical Study of the Solo Tympanostomy Tube Device
- Conditions
- Ear InfectionOtitis Media
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2019-10-28
- Lead Sponsor
- AventaMed DAC
- Target Recruit Count
- 27
- Registration Number
- NCT03722160
- Locations
- 🇮🇹
IRCCS Burlo-Garofolo, Trieste, Italy
🇬🇧Royal Derby Hospital, Derby, United Kingdom
🇬🇧Queen's Medical Centre, Nottingham, United Kingdom
